CannaPharmaRX (CPMD) Short Interest Ratio & Short Volume $0.0085 0.00 (-15.00%) (As of 11/13/2024 05:36 PM ET) Add Compare Share Share Short Interest Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest CannaPharmaRX Short Interest DataCannaPharmaRX (CPMD) has a short interest of 1,100 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 1.28 million shares to cover all short positions.Current Short Interest1,100 sharesPrevious Short Interest1,100 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$8.80Short Interest Ratio0.0 Days to CoverLast Record DateSeptember 15, 2024Outstanding Shares660,630,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume289,774 sharesAverage Trading Volume1,276,240 sharesToday's Volume Vs. Average23% Short Selling CannaPharmaRX? Sign up to receive the latest short interest report for CannaPharmaRX and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCPMD Short Interest Over TimeCPMD Days to Cover Over TimeCPMD Percentage of Float Shorted Over Time Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…Get Your Free Gold Guide CannaPharmaRX Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/15/20241,100 shares $8.80 No ChangeN/A0 $0.01 8/31/20241,100 shares $10.45 No ChangeN/A0 $0.01 8/15/20241,100 shares $11.00 +83.3%N/A0 $0.01 7/31/2024600 shares $6.00 No ChangeN/A0 $0.01 4/15/20241,000 shares $15.00 -47.4%N/A0 $0.02 3/31/20241,900 shares $28.12 +26.7%N/A0 $0.01 Get the Latest News and Ratings for CPMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CannaPharmaRX and its competitors with MarketBeat's FREE daily newsletter. 3/15/20241,500 shares $18.75 No ChangeN/A0 $0.01 7/15/202323,000 shares $315.10 No ChangeN/A0.1 $0.01 5/15/2023142,700 shares $1,412.73 +2,812.2%N/A0.2 $0.01 4/30/20234,900 shares $49.00 -69.2%N/A0 $0.01 4/15/202315,900 shares $155.03 +20.5%N/A0 $0.01 3/31/202313,200 shares $118.80 No ChangeN/A0 $0.01 2/15/202330,500 shares $323.30 -34.6%N/A0 $0.01 1/31/202346,600 shares $605.80 +58.0%N/A0 $0.01 1/15/202329,500 shares $383.50 +5,800.0%N/A0 $0.01 12/30/2022500 shares $5.00 No ChangeN/A0 $0.01 11/15/20221,600 shares $18.08 -98.2%N/A0 $0.01 10/31/202290,700 shares $907.00 +18.6%N/A0.1 $0.01 10/15/202276,500 shares $925.65 +68.1%N/A0.1 $0.01 9/30/202245,500 shares $632.45 -52.4%N/A0 $0.01 9/15/202295,600 shares $975.12 +223.0%N/A0 $0.01 8/31/202229,600 shares $390.72 +60.0%N/A0 $0.01 8/15/202218,500 shares $244.20 -45.4%N/A0 $0.01 7/31/202233,900 shares $601.73 No ChangeN/A0 $0.02 6/30/2022558,200 shares $9,098.66 +2,777.3%N/A0.1 $0.02 6/15/202219,400 shares $194.00 -24.2%N/A0 $0.01 5/31/202225,600 shares $307.20 No ChangeN/A0 $0.01 4/30/20226,400 shares $112.00 No ChangeN/A0 $0.02 3/31/202268,400 shares $1,128.60 +19.4%N/A0 $0.02 3/15/202257,300 shares $779.28 -30.3%N/A0 $0.01 2/28/202282,200 shares $1,233.00 +3,636.4%N/A0 $0.02 2/15/20222,200 shares $52.80 -70.3%N/A0 $0.02 1/31/20227,400 shares $103.60 +7,300.0%N/A0 $0.01 1/15/2022100 shares $1.90 No ChangeN/A0 $0.02 12/31/2021100 shares $1.30 -83.3%N/A0 $0.01 12/15/2021600 shares $9.00 +500.0%N/A0 $0.02 11/30/2021100 shares $2.11 -98.0%N/A0 $0.02 11/15/20214,900 shares $122.01 -54.6%N/A0 $0.02 10/29/202110,800 shares $198.72 -88.9%N/A0 $0.02 10/15/202197,600 shares $3,416.00 No ChangeN/A0.1 $0.04Central Bank Abandons USD (Ad)Startling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – the United States Dollar… And placing a ‘quiet bet’ on a new type of currency… Gold. Click here now to get your free 'Protect Your Wealth' Guide. 9/15/202119,300 shares $596.37 +1,035.3%N/A0 $0.03 8/31/20211,700 shares $46.58 No ChangeN/A0 $0.03 8/13/20211,700 shares $50.83 -95.8%N/A0 $0.03 7/30/202140,200 shares $1,648.20 +905.0%N/A0 $0.04 7/15/20214,000 shares $156.80 -91.4%N/A0 $0.04 6/30/202146,700 shares $2,311.65 +7,683.3%N/A0 $0.05 6/15/2021600 shares $37.80 -98.2%N/A0 $0.06 5/28/202133,400 shares $4,335.32 +18.0%N/A0.3 $0.13 5/14/202128,300 shares $4,389.33 +262.8%N/A0.1 $0.16 4/30/20217,800 shares $1,560.00 -33.9%N/A0.1 $0.20 4/15/202111,800 shares $2,891.00 +151.1%N/A0.1 $0.25 3/31/20214,700 shares $1,127.53 -69.9%N/A0 $0.24 3/15/202115,600 shares $4,212.00 +1,100.0%N/A0 $0.27 2/26/20211,300 shares $611.00 -96.5%N/A0 $0.47 2/12/202137,200 shares $19,269.60 -54.6%N/A0.1 $0.52 1/29/202181,900 shares $30,303.00 +453.4%N/A0.3 $0.37 1/15/20217,400 shares $3,552.00 +45.1%N/A0 $0.48 12/31/20209,600 shares $4,656.00 +29.7%N/A0 $0.49 12/15/20207,400 shares $1,839.64 +45.1%N/A0 $0.25 11/30/20205,100 shares $1,841.10 +10.9%N/A0.1 $0.36 11/15/20204,600 shares $1,702.00 +27.8%N/A0.1 $0.37 10/30/20203,600 shares $1,512.00 No ChangeN/A0.1 $0.42 10/15/20203,600 shares $1,800.00 -23.4%N/A0 $0.50 9/30/20204,700 shares $2,820.00 +213.3%N/A0 $0.60 9/15/20201,500 shares $959.85 -59.5%N/A0 $0.64 8/31/20203,700 shares $4,625.00 +48.0%N/A0 $1.25 8/14/20202,500 shares $0.00 +1,150.0%N/A0 $0.00 CPMD Short Interest - Frequently Asked Questions What is CannaPharmaRX's current short interest? Short interest is the volume of CannaPharmaRX shares that have been sold short but have not yet been closed out or covered. As of September 15th, traders have sold 1,100 shares of CPMD short. Learn More on CannaPharmaRX's current short interest. How does CannaPharmaRX's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to CannaPharmaRX: GeoVax Labs, Inc. (3.59%), Enlivex Therapeutics Ltd. (0.75%), HST Global, Inc. (0.00%), MIRA Pharmaceuticals, Inc. (12.65%), Lisata Therapeutics, Inc. (0.25%), Cognition Therapeutics, Inc. (2.41%), Palatin Technologies, Inc. (6.23%), Bullfrog AI Holdings, Inc. (4.76%), Lakeshore Biopharma Co., Ltd. (0.42%), Spruce Biosciences, Inc. (0.56%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($6.15 billion), Charter Communications, Inc. ($4.04 billion), Paychex, Inc. ($2.77 billion), Nu Holdings Ltd. ($2.71 billion), Cencora, Inc. ($2.34 billion), Aptiv PLC ($2.18 billion), Tractor Supply ($2.07 billion), International Paper ($2.01 billion), AppLovin Co. ($1.95 billion), and Moderna, Inc. ($1.89 billion). View all of the most shorted stocks. What does it mean to sell short CannaPharmaRX stock? Short selling CPMD is an investing strategy that aims to generate trading profit from CannaPharmaRX as its price is falling. CPMD shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against CannaPharmaRX? A short squeeze for CannaPharmaRX occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CPMD, which in turn drives the price of the stock up even further. How often is CannaPharmaRX's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CPMD, twice per month. The most recent reporting period available is September, 15 2024. More Short Interest Resources from MarketBeat Related Companies GeoVax Labs Short Squeeze Enlivex Therapeutics Short Squeeze HST Global Short Squeeze MIRA Pharmaceuticals Short Squeeze Lisata Therapeutics Short Squeeze Cognition Therapeutics Short Squeeze Palatin Technologies Short Squeeze Bullfrog AI Short Squeeze Lakeshore Biopharma Short Squeeze Spruce Biosciences Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:CPMD) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredIs Your 401(k) Safe? The Real Risk No One Sees ComingEvery day you wait, your savings are at greater risk. The government isn't slowing down, inflation isn't stopp...Golden Crest | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CannaPharmaRX, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CannaPharmaRX With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.